Aspergillosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 11thDecember 2014
Summary The industry analysis specialist, has released its new report, “Aspergillosis Therapeutics Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Aspergillosis Therapeutics market. The report identifies the key trends shaping and driving the global Aspergillosis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Aspergillosis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-aspergillosis-therapeutics-pipeline-assessment-and-market-forecasts135200 Scope The report provides information on the key drivers and challenges of the Aspergillosis Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Aspergillosis Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Aspergillosis Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Aspergillosis Therapeutics market. - Analysis of key recent licensing and partnership agreements in Aspergillosis Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Aspergillosis Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Aspergillosis Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Aspergillosis Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Aspergillosis Therapeutics - Introduction 2.1 Overview 2.2 Epidemiology 2.3 Etiology 2.4 Symptoms 2.5 Diagnosis 2.6 Pathophysiology 2.7 Treatment and Management Pattern 2.8 GlobalData Pipeline Report Guidance 3 Aspergillosis Therapeutics - Market Characterization 3.1 Overview 3.2 Aspergillosis Therapeutics Market Size (2006-2011) - Global 3.3 Aspergillosis Therapeutics Market Forecast (2011-2019) - Global 3.4 Aspergillosis Therapeutics Market Size (2006-2011) - The US 3.5 Aspergillosis Therapeutics Market Forecast (2011-2019) - The US 3.6 Aspergillosis Therapeutics Market Size (2006-2011) - France 3.7 Aspergillosis Therapeutics Market Forecast (2011-2019) - France 3.8 Aspergillosis Therapeutics Market Size (2006-2011) - Germany Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.9 Aspergillosis Therapeutics Market Forecast (2011-2019) - Germany 3.10 Aspergillosis Therapeutics Market Size (2006-2011) - Italy 3.11 Aspergillosis Therapeutics Market Forecast (2011-2019) - Italy 3.12 Aspergillosis Therapeutics Market Size (2006-2011) - Spain 3.13 Aspergillosis Therapeutics Market Forecast (2011-2019) - Spain 3.14 Aspergillosis Therapeutics Market Size (2006-2011) - The UK 3.15 Aspergillosis Therapeutics Market Forecast (2011-2019) - The UK 3.16 Aspergillosis Therapeutics Market Size (2006-2011) - Japan 3.17 Aspergillosis Therapeutics Market Forecast (2011-2019) - Japan 3.18 Drivers and Barriers for the Aspergillosis Therapeutics Market 3.18.1 Drivers for the Aspergillosis Therapeutics Market 3.18.2 Barriers for the Aspergillosis Therapeutics Market 3.19 Opportunity and Unmet Need 3.20 Key Takeaway 4 Aspergillosis Therapeutics Market - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles of the Major Marketed Products in the Aspergillosis Therapeutics Market Heparin Class 4.3.1 Voriconazole (Vfend) 4.3.2 Posaconazole (Noxafil) 4.3.3 Itraconazole (Sporanox) 4.3.4 Caspofungin (Cancidas) 4.3.5 Amphotericin B (Amphocin) 4.4 Key Takeaway 5 Aspergillosis Therapeutics Market - Pipeline Assessment 5.1 Overview 5.1.1 Aspergillosis Therapeutics - Phase III Clinical Pipeline 5.1.2 Aspergillosis Therapeutics - Phase II Clinical Pipeline 5.1.3 Aspergillosis Therapeutics - Phase I Clinical Pipeline 5.1.4 Aspergillosis Therapeutics - Preclinical and Discovery Clinical Pipeline 5.2 Aspergillosis Therapeutics Market - Pipeline Assessment by Mechanism of Action 5.3 Aspergillosis Therapeutics Market - Technology Trends Analytical Framework 5.4 Aspergillosis Therapeutics Market - Pipeline Assessment by Clinical Phase of Development 5.5 Molecule Profile for Drugs under Clinical Development 5.5.1 Isavuconazole 5.5.2 SPK-843 5.6 Key Takeaway 6 Aspergillosis Therapeutics - Clinical Trials Mapping Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
6.1 Clinical Trials by Region/Country 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Prominent and Overall Sponsors 6.5 Brief Profiles of Top 10 Companies Participating in Clinical Trials 7 Aspergillosis Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Aspergillosis Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Pfizer Inc. 8.2.2 Astellas Pharma Inc. 8.2.3 Basilea Pharmaceutica Ltd. (Basilea) 9 Aspergillosis Therapeutics - Acquisition Deals 10 Aspergillosis Therapeutics Market - Appendix 10.1 Market Definition 10.2 Abbreviations 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables Table 1: Aspergillosis Therapeutics Market, Global, Revenues ($m), 2006-2011 Table 2: Aspergillosis Therapeutics Market, Global, Market Forecasts ($m), 2011-2019 Table 3: Aspergillosis Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 4: Aspergillosis Therapeutics Market, The US, Market Forecasts ($m), 2011-2019 Table 5: Aspergillosis Therapeutics Market, France, Revenue ($m), 2006-2011 Table 6: Aspergillosis Therapeutics Market, France, Market Forecast ($m), 2011-2019 Table 7: Aspergillosis Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 8: Aspergillosis Therapeutics Market, Germany, Market Forecast ($m), 2011-2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 9: Aspergillosis Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 10: Aspergillosis Therapeutics Market, Italy, Market Forecast ($m), 2011-2019 Table 11: Aspergillosis Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 12: Aspergillosis Therapeutics Market, Spain, Market Forecast ($m), 2011-2019 Table 13: Aspergillosis Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 14: Aspergillosis Therapeutics Market, The UK, Market Forecast ($m), 2011-2019 Table 15: Aspergillosis Market, Japan, Revenue ($m), 2006-2011 Table 16: Aspergillosis Therapeutics Market, Japan, Market Forecast ($m), 2011-2019 Table 17: Aspergillosis Therapeutics Market - Phase III Clinical Pipeline, 2010 Table 18: Aspergillosis Therapeutics Market - Phase II Clinical Pipeline, 2010 Table 19: Aspergillosis Therapeutics Market - Phase I Clinical Pipeline, 2010 Table 20: Aspergillosis Therapeutics Market - Preclinical Pipeline, 2010 Table 21: Aspergillosis Market, Global, Clinical Trials by Country, 2010 Table 22: Aspergillosis Market, Global, Clinical Trials by Phase, 2010 Table 23: Aspergillosis Market, Global, Clinical Trials by Status of Development, 2010 Table 24: Aspergillosis Market, Global, Sponsors, 2010 Table 25: Aspergillosis Market, Global, Companies by Phase, 2010 Table 26: Aspergillosis Therapeutics, Global, Deals, 2011
List Of Figures Figure 1: Aspergillosis Therapeutics Market, Global, Revenues ($m), 2006-2011 Figure 2: Aspergillosis Therapeutics Market, Global, Market Forecast ($m), 2011-2019 Figure 3: Aspergillosis Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 4: Aspergillosis Therapeutics Market, The US, Market Forecasts ($m), 2011-2019 Figure 5: Aspergillosis Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 6: Aspergillosis Therapeutics Market, France, Market Forecast ($m), 2011-2019 Figure 7: Aspergillosis Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 8: Aspergillosis Therapeutics Market, Germany, Market Forecast ($m), 2011-2019 Figure 9: Aspergillosis Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 10: Aspergillosis Therapeutics Market, Italy, Market Forecast ($m), 2011-2019 Figure 11: Aspergillosis Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 12: Aspergillosis Therapeutics Market, Spain, Market Forecast ($m), 2011-2019 Figure 13: Aspergillosis Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 14: Aspergillosis Therapeutics Market, The UK, Market Forecast ($m), 2011-2019 Figure 15: Aspergillosis Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 16: Aspergillosis Therapeutics Market, Japan, Market Forecast ($m), 2011-2019 Figure 17: Opportunity and Unmet Need in the Aspergillosis Therapeutics Market Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 18: Strategic Competitor Assessment of the Marketed Products for Aspergillosis, 2010 Figure 19: Aspergillosis Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2010 Figure 20: Technology Trends Analytic Framework of the Aspergillosis Pipeline, 2010 Figure 21: Technology Trends Analytic Framework of the Aspergillosis Pipeline - Description, 2010 Figure 22: Aspergillosis Pipeline by Phase of Clinical Development, 2010 Figure 23: Aspergillosis Market, Global, Clinical Trials by Country, 2010 Figure 24: Aspergillosis Market, Global, Clinical Trials by Phase, 2010 Figure 25: Aspergillosis Market, Global, Clinical Trials by Stage of Development, 2010 Figure 26: Aspergillosis Market, Global, Prominent Sponsors, 2010 Figure 27: Aspergillosis Market, Global, Overall Sponsors, 2010 Figure 28: Aspergillosis, Market, Global, Companies by Phase, 2010 Figure 29: Aspergillosis Market, Drivers and Barriers, 2010 Figure 30: Implications for Future Market Competition in the Aspergillosis Therapeutics Market, 2011 Figure 31: Aspergillosis Therapeutics Market - Clinical Pipeline by Company, 2010 Figure 32: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Methicillin-resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Aspergillosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-aspergillosistherapeutics-pipeline-assessment-and-market-forecasts-135200
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/